An interventional study of Zumba fitness programme in Hypertension, sponsored by Universidad de Extremadura. Completed at 1 site in Spain. Per ClinicalTrials.gov, last updated 2026-07-30.
Sponsored by Universidad de Extremadura · Not applicable, Interventional, and Treatment
This study aims to evaluate the effects of a 10-week Zumba-based exercise program performed three times per week on blood pressure in adults with hypertension. In addition to the primary outcome of blood pressure, secondary outcomes including medication control, body composition (body weight, body fat percentage, and muscle mass), and psychological outcomes (anxiety, depression, quality of life, emotional well-being, and sleep quality) will be assessed.
Participants will be assigned to either an intervention group, performing the Zumba program, or a control group maintaining their usual lifestyle. Measurements will be conducted at baseline and after the intervention period to determine the effectiveness of the program.
Hypertension is a major public health concern associated with increased cardiovascular risk. Regular physical activity has been shown to improve blood pressure control and overall health outcomes. Zumba, as a form of aerobic exercise combining dance and music, may represent an engaging and effective intervention to improve adherence to physical activity programs.
The aim of this study is to investigate the effects of a 10-week Zumba-based exercise intervention, performed three times per week, on blood pressure in adults with hypertension. Secondary objectives include the assessment of changes in medication use, body composition (body weight, body fat percentage, and muscle mass), and psychological outcomes, including anxiety and depression symptoms, quality of life, emotional well-being, and sleep quality.
Participants will be allocated to either an intervention group or a control group. The intervention group will participate in supervised Zumba sessions, while the control group will maintain their usual daily activities. All participants will undergo assessments at baseline and after the 10-week intervention period.
6,114 studies on the registry are indexed under Hypertension; 912 are open to participants now.
This study's enrollment of 46 is below the median of 100 across 4,575 interventional studies indexed under Hypertension.
Browse Hypertension studies →Universidad de Extremadura is the lead sponsor of 39 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants in this group will perform a supervised Zumba-based exercise program for 10 weeks, with a frequency of three sessions per week. Each session will consist of moderate-intensity aerobic exercise based on dance movements.
Behavioral: Zumba fitness programme
Participants in this group will maintain their usual lifestyle and will not participate in the structured exercise program during the study period.
Aquí tienes la descripción para el campo de intervención en ClinicalTrials.gov: A 10-week supervised Zumba Fitness programme consisting of three 50-minute sessions per week on non-consecutive days. Each session was structured in three phases: a warm-up (7 minutes), a main part (36 minutes) based on choreographed Latin dance rhythms (merengue, salsa, reggaeton, cumbia, bachata, among others) following a wave-like intensity pattern, and a cool-down (7 minutes). Sessions were led by a certified Zumba Instructor Network (ZIN) instructor with more than 10 years of experience. Internal load was self-regulated by participants using the Borg CR-10 scale, targeting moderate-to-hard effort levels (RPE 4-6). The control group maintained their usual sedentary lifestyle without participating in any structured exercise programme during the intervention period.
Change in Systolic and Diastolic Blood Pressure
Blood pressure will be measured at baseline and after the 10-week intervention using a validated sphygmomanometer.
Time frame: Baseline and 10 weeks
Ran from Apr 2026 to primary completion in Jul 2026, 2 months.
Of 1,403 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 2 months is below that.
Counting every sponsor, half of 1,498 studies reached it within 23 months; a quarter within 10 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad de Extremadura